Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marshall Austin

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Archives of Pathology & Laboratory Medicine|July 23, 2003
Human papillomavirus reporting: minimizing patient and laboratory riskR Marshall Austin
Diagnostic Cytopathology|July 8, 2010
Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risksR Marshall Austin
Cancer|February 18, 2003
Public expectations, achievable cervical screening sensitivity, and the standard of practiceR Marshall Austin
Archives of Pathology & Laboratory Medicine|February 4, 2003
The detection of precancerous cervical lesions can be significantly increasedR Marshall Austin
Acta Cytologica|July 11, 2017
George Papanicolaou's Efforts to Develop Novel Cytologic Methods for the Early Diagnosis of Endometrial CarcinomaR Marshall Austin
Journal of the American Society of Cytopathology|May 3, 2019
The coming human papillomavirus (HPV) test-driven colposcopy tsunamiR Marshall Austin
Archives of Pathology & Laboratory Medicine|February 7, 2008
Dismantling of the U.S. cytotechnology educational infrastructure is premature and carries significant risksR Marshall Austin
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 25, 2015
HPV primary screening: unanswered questionsR Marshall Austin
Cancer Cytopathology|March 26, 2010
Computer-assisted Papanicolaou imaging : another valuable tool in the challenge of Papanicolaou test screening for glandular neoplasiaR Marshall Austin
Diagnostic Cytopathology|February 27, 2004
New cervical cancer screening guidelines: the other side of group health care "rights"R Marshall Austin
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Archives of Pathology & Laboratory Medicine|July 23, 2003
Human papillomavirus reporting: minimizing patient and laboratory riskR Marshall Austin
Diagnostic Cytopathology|July 8, 2010
Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risksR Marshall Austin
Cancer|February 18, 2003
Public expectations, achievable cervical screening sensitivity, and the standard of practiceR Marshall Austin
Archives of Pathology & Laboratory Medicine|February 4, 2003
The detection of precancerous cervical lesions can be significantly increasedR Marshall Austin
Acta Cytologica|July 11, 2017
George Papanicolaou's Efforts to Develop Novel Cytologic Methods for the Early Diagnosis of Endometrial CarcinomaR Marshall Austin
Journal of the American Society of Cytopathology|May 3, 2019
The coming human papillomavirus (HPV) test-driven colposcopy tsunamiR Marshall Austin
Archives of Pathology & Laboratory Medicine|February 7, 2008
Dismantling of the U.S. cytotechnology educational infrastructure is premature and carries significant risksR Marshall Austin
Cytopathology : Official Journal of the British Society for Clinical Cytology|November 25, 2015
HPV primary screening: unanswered questionsR Marshall Austin
Cancer Cytopathology|March 26, 2010
Computer-assisted Papanicolaou imaging : another valuable tool in the challenge of Papanicolaou test screening for glandular neoplasiaR Marshall Austin
Diagnostic Cytopathology|February 27, 2004
New cervical cancer screening guidelines: the other side of group health care "rights"R Marshall Austin
Pageof 11